机译:基于共价对接模拟的三肽基环氧基酮蛋白酶体抑制剂的发现,由脂族杂环组成
Zhejiang Univ ZJU ENS Joint Lab Med Chem Zhejiang Prov Key Lab Anticanc Drug Res Hangzhou Inst;
Zhejiang Univ ZJU ENS Joint Lab Med Chem Zhejiang Prov Key Lab Anticanc Drug Res Hangzhou Inst;
Chinese Acad Sci Shanghai Inst Mat Med State Key Lab Drug Res Natl Ctr Drug Screening Shanghai;
Zhejiang Univ ZJU ENS Joint Lab Med Chem Zhejiang Prov Key Lab Anticanc Drug Res Hangzhou Inst;
Zhejiang Chinese Med Univ Coll Pharmaceut Sci Hangzhou 311402 Zhejiang Peoples R China;
Chinese Acad Sci Shanghai Inst Mat Med State Key Lab Drug Res Natl Ctr Drug Screening Shanghai;
Chinese Acad Sci Shanghai Inst Mat Med State Key Lab Drug Res Natl Ctr Drug Screening Shanghai;
Chinese Acad Sci Shanghai Inst Mat Med State Key Lab Drug Res Natl Ctr Drug Screening Shanghai;
Chinese Acad Sci Shanghai Inst Mat Med State Key Lab Drug Res Natl Ctr Drug Screening Shanghai;
Zhejiang Univ ZJU ENS Joint Lab Med Chem Zhejiang Prov Key Lab Anticanc Drug Res Hangzhou Inst;
Zhejiang Univ ZJU ENS Joint Lab Med Chem Zhejiang Prov Key Lab Anticanc Drug Res Hangzhou Inst;
Chinese Acad Sci Shanghai Inst Mat Med State Key Lab Drug Res Natl Ctr Drug Screening Shanghai;
Proteasome inhibitors; Tripeptide; Covalent docking; Interaction mode;
机译:基于共价对接模拟的三肽基环氧基酮蛋白酶体抑制剂的发现,由脂族杂环组成
机译:以β-氨基酸为蛋白酶体抑制剂的新型三肽基环氧酮衍生物的设计,合成及生物学评价
机译:从β-氨基酸构成的β-氨基酸作为蛋白酶体抑制剂构建的新型三肽基环氧基酮衍生物的设计,合成和生物学评价
机译:蛋白酶体模型与肽醛抑制剂MG132和MG101的共价配合物:对接和分子动力学研究
机译:第一部分。设计用于人类颗粒酶B(hBrB)的新型可逆非共价小分子抑制剂。第二部分。姜黄素和模拟物作为蛋白酶体抑制剂第三部分。新型的针对雌激素受体α的共激活因子结合抑制剂(CBI)的设计:打破1μM的障碍。
机译:组合的3D-QSAR,分子对接和分子动力学研究肽环氧酮和酪肽素-硼酸作为抗人20S蛋白酶体β5亚基的抑制剂
机译:组合的3D-QSAR,分子对接和分子动力学研究肽环氧酮和酪肽素-硼酸作为抗人20S蛋白酶体β5亚基的抑制剂